Dengue is a mosquito-borne disease caused by four closely related dengue virus (genus Flavivirus) serotypes (DENV-1-4). The clinical outcomes vary from mild febrile illness to life-threatening haemorrhagic manifestations. DENVs are endemic in the tropics and subtropics globally and currently no specific treatment or vaccines are available. In Venezuela, the American-Asian genotype of DENV-2 is the most prevalent and has been associated with severe disease outcomes. We aimed to follow-up the molecular epidemiology of DENV-2 in Venezuela to investigate if the evolution of the virus has remained the same throughout time or if the same dynamics documented in Brazil (hyperendemic co-circulation) also occurred. The results show that whereas the epidemiology of DENV in several endemic areas is characterized by serotype replacements through time, in Venezuela the American-Asian genotype DENV-2 has evolved into several genetic lineages and has remained in hyperendemic co-circulation with the other serotypes.
INTRODUCTION
Dengue is a mosquito-borne viral disease caused by four closely related dengue virus serotypes (DENV-1-4) belonging to the genus Flavivirus. DENVs are positive-sense single-stranded enveloped RNA viruses that are transmitted by Aedes spp. mosquitoes [1] . The clinical outcomes are categorized according to the disease severity into dengue fever (DF), dengue haemorrhagic fever (DHF) and dengue shock syndrome (DSS) [2] . DENVs are endemic in more than 100 countries in the subtropics and tropics of the world causing an estimated 50-100 million infections annually ; currently no specific treatment or vaccines are available [3] .
Dengue is a significant public health problem in Latin America. During the last 30 years an almost fivefold increase in reported cases has been observed [4] . In this region, DENV-2 has been involved in epidemics for several decades [5] [6] [7] [8] . DENV-2 viruses so far have been genetically categorized into six genotypes, one representing the isolates found in sylvatic cycles involving primates while the others are associated with human epidemics [9] [10] [11] [12] . The DENV-2 genotype, originally found in the Americas, was designated as the American genotype. This genotype was prevalent in Latin America until the early 1980s when a novel genotype of Asiatic origin, known as American-Asian genotype [13] or subtype III [9] was introduced into the area [6] . Unlike the American genotype, the new American-Asian genotype was associated with severe disease including DHF and DSS [14, 15] . This genotype spread rapidly and became the predominant DENV-2 genotype in the area [6, 7, 9, 15, 16] .
The highest numbers of DHF cases in the Latin American region are reported from Venezuela, where currently all four DENV types are co-circulating. In 2007, DHF incidence in Venezuela was 62 . 9/100000 in infants [4] . Previously DENV-2 was associated with severe disease and fatalities in Venezuela, and was shown to evolve locally [17] [18] [19] . DENV-2 is still circulating in Venezuela ; however, the more recent virus genotype and lineage compositions are unknown. The aim of this study was to follow-up the molecular epidemiology of DENV-2 in Venezuela by analysing a set of previously uncharacterized isolates and the available database sequences, which overall encompass a time-frame spanning more than 15 years.
MATERIALS AND METHODS

Virus strains and epidemiological data
The materials and epidemiological information were collected at the Regional Laboratory of Aragua state, Maracay, which is a centre for DENV research in Venezuela. The laboratory performs routine serological diagnostics of dengue and DENV serotyping by reverse transcription-polymerase chain reaction (RT-PCR) [20] and collects epidemiological data including numbers of diagnosed cases, clinical disease severity classifications according to the WHO [2] and the proportions of different DENV serotypes detected in DENV by RT-PCR typing. From all the diagnosed cases, the early serum samples are additionally studied by virus isolation in Aedes albopictus C6/36 cells and serotyped using DENV-type specific monoclonal antibodies [21] in immunofluorescence assay. All DENV-2 isolates obtained during 1999-2005 were included in this study, comprising of 23 previously uncharacterized strains.
RT-PCR and sequencing
The viral RNA was extracted from supernatants of infected C6/36 cells by using QiaAmp Viral RNA Mini kit (Qiagen, USA) according to the manufacturer's instructions. The envelope gene regions were amplified by RT-PCR using Expand Reverse Transcriptase (Roche, USA) and recombinant Taq DNA polymerase (Fermentas, USA) and Taq Extender (Stratagene, USA) using previously described primers [19] . The PCR products were purified using ExoZAP-IT (USB Laboratories, USA) and directly sequenced using a set of DENV-2 envelope gene specific primers (Supplementary Table S1 ).
Phylogenetic analysis
The sequence analysis was performed for 122 DENV-2 envelope gene sequences including the 23 DENV-2 strains sequenced in this study and 55 Venezuelan DENV-2 viruses for which the complete envelope gene sequence was available in the GenBank database (accessed in February 2012). Additionally, sequences from neighbouring countries sharing high identity percentages with the Venezuelan isolates and a global selection of DENV-2 sequences representing the epidemic DENV-2 genotypes were included (Supplementary Table S2 ). The sequences were aligned using MUSCLE (http://www.ebi.ac.uk/ Tools/msa/muscle/) and the phylogenetic analysis was performed using the Bayesian approach implemented in BEAST [22] . The HKY-G-I model of nucleotide substitution was used, convergence of parameters was assessed using Tracer v. 1.4 (http://beast.bio.ed.ac.uk/ Tracer) and each run was continued until the effective sampling size of all parameters was >200. The available complete genome sequences of Venezuelan isolates (n=31) were further examined for the presence of recombination events using SimPlot (http://sray. med.som.jhmi.edu/SCRoftware/simplot/) and RDP (http://darwin.uvigo.es/rdp/rdp.html).
RESULTS
DENV-2 isolates studied here originated from the period 1999-2005 (Table 1) . During this period, the only year with no isolates was 2002. The sequence analysis of Venezuelan DENV-2 envelope gene sequences including the 23 DENV-2 strains sequenced in this study suggested that the Venezuelan isolates fell into six genetic lineages exclusively within the American-Asian genotype ( In the previous study consisting of Venezuelan DENV-2 E isolates obtained between 1997 and 2000, three genetic lineages were separated, including two main groups and one strain that was not clearly associated with either of the main lineages [19] . These groups are now implemented within lineages I, V and VI in the current tree. Most of the available sequence data of Venezuelan DENV-2 consists of E-gene sequences. No evidence of recombination could be detected in the strains included in this analysis. The rarity of recombination was also confirmed by analysis of the available complete genome sequences of Venezuelan isolates (n=31) that showed no evidence of recombination besides the previously described recombination in the preM gene of MARA4 strain [19] (data not shown).
The Venezuelan DENV-2 sequences determined in this study had envelope protein amino acid changes located in domains II and III, including the amino acid signature described for the AmericanAsian genotype [7] defined by E91 :I, E129 :V, DF, Dengue fever ; DHF, dengue haemorrhagic fever ; n.d., no data. E131:Q, E390 :N and E485 :V. A total of 12 additional amino-acid substitutions were observed, some of them exclusively found in Venezuelan strains (Supplementary Table S3 ). In DENV-2 strains from Puerto Rico, the typical American-Asian genotype envelope gene domain I substitutions were associated with additional changes in the domain III, in positions E491 or E359 [16] . Six of our Venezuelan isolates had similarly additional change in E359, from threonine to isoleucine. The results of RT-PCR typing of DENV serotypes circulating in 1997-2008 suggest that the serotype composition had varied from year to year (Supplementary Fig. S1 ). Moreover, a change from three circulating serotypes (DENV-1, x2, x4) to the cocirculation of all four DENV serotypes had occurred since 2000. Within this time-frame the years 1997 and 1999 had low numbers of DENV diagnoses, and these were the only years that DENV-2 was the predominant serotype. After 1999, DENV-3 and DENV-1 were detected more often than DENV-2, which was also the case during the peak years of 2001 and 2007.
DISCUSSION
The new sequence data obtained in this study combined with the existing database sequences of DENV-2 provide a long-term insight to the molecular epidemiology of DENV-2 in Venezuela, and demonstrate a wide local diversification of strains belonging to the American-Asian genotype. In this study no other genotypes of DENV-2 were detected, which is in line with previous studies [19, 23] suggesting that since the introduction of the American-Asian genotype in the 1980s DENV-2 has evolved locally in Venezuela.
Since the previous comprehensive study of Venezuelan DENV-2 in 1997-2000 [19] , the genetic diversification of DENV-2 has continued, and instead of three lineages, the strains are now separated into six separate lineages. The Venezuelan DENV-2 strains were only partly temporally clustered, suggesting co-circulation of variable strains. The E gene sequences determined in this study, and their comparisons to database sequences suggest that the Venezuelan DENV-2 strains had some unique amino acid changes, that may serve as identifiers for strains of Venezuelan origin. However, as no associations with disease severity could be made with any of the defined amino acid changes (or described phylogenetic lineages), further studies will be required to elucidate their possible biological significance.
The available information on the circulating DENV serotypes in 1997-2008 was based on results of RT-PCR typing of DENV that were not available for all diagnosed patients. However, the available data of RT-PCR-positive patients suggest that cocirculation of all four DENV serotypes had occurred since 2000, the time when DENV-2 also seemed to have fallen from the position of a 'leading ' serotype. The lowered numbers of DENV-2 could be explained by the previous massive DENV-2 epidemics that probably left the majority of the population immune to this serotype, and additionally, the co-circulation of the other serotypes could have impaired DENV-2 transmission through short-term cross-protection [24] . However, DENV-2 was detected each year, demonstrating that it was not completely replaced by the other serotypes.
In addition to Venezuela, the local evolution and survival of the American-Asian genotype DENV-2 in co-circulation with the other serotypes was also observed in Puerto Rico and Brazil [25] [26] [27] . In Venezuela, DENV-2 has not been the major cause of DENV epidemics for a number of years, but it may have the capability to re-emerge, as previously seen in Puerto Rico [25] .
The maintenance and re-emergence of a certain DENV serotype or genotype seems to be a more rare observation than the introduction and replacement pattern observed in many endemic countries [28] [29] [30] . Currently the epidemiological and ecological factors behind these different patterns are poorly understood. The American-Asian genotype DENV-2 has been experimentally shown to have relatively high fitness in both humans and mosquitoes [31, 32] , which may explain its survival in competition with other circulating DENVs. While epidemiological studies often concentrate on the detection and study of DENV from clinically ill patients, enlightening information could be obtained by monitoring and studying asymptomatic individuals and mosquitoes. The detailed understanding of DENV endemicity, including maintenance, is important for successful prevention and control strategies in the affected areas, such as Venezuela.
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